Biphoo Feedback
Please Contact Us
Captcha *
Biphoo
Health
Omeprazole+SyrSpend SF Alka
468x15 ads here
Omeprazole+SyrSpend SF Alka Overview

being available from a number of generic manufacturers. omeprazole is available in both tablet and capsule form, with varying strengths of each.

The need for other administration options for those patients who can used in the treatment of dyspepsia, peptic not take tablets or capsules has led compounding pharmacies to seek other alternatives. one possible alternative is the use of a suspending ryngeal reflux (LPR), and Zollinger–Ellison agent to create an oral solution or suspension. In the past, this has been syndrome.1 It is used to treat a wide range accomplished using a sodium bicarbonate solution as the vehicle. How- of the patient population, including both ever, sodium bicarbonate/omeprazole combination imparts a bitter and infant and geriatric patients. These two unpleasant taste. SyrSpend SF Alka (reconstituted) is a vehicle for mak- groups in particular may experience dif-ficulty in swallowing whole capsules or ing a suspension which has a pleasant taste, thus increasing palpability tablets. In the past, sodium bicarbonate and compliance. The objective of this study was to determine the stability of omeprazole in SyrSpend SF Alka (for reconstitution). The studied an oral solution. Sodium bicarbonate does sample was compounded into a 2-mg/ml suspension and stored in a little to mask the bitter taste of omeprazole. low-actinic plastic prescription bottle at temperatures between 2oC and 8oC. Six samples were assayed at each time point out to 92 days by a sweetener masks the bitter taste and increases the palpability of omeprazole. stability-indicating high-performance liquid chromatography method.The method was validated for its specificity through forced degradation considering the treatment of infants, as the studies. The shelf life of this product is at least 92 days, based on data collected when refrigerated and protected from light.

The objective of this study was to exam- matographic (HPLC)-grade acetonitrile (Lot Conditionsine the stability of omeprazole when pre- Two different types of HPLCs were used. pared in an oral suspension using SyrSpend Michigan), 85% phosphoric acid ACS-grade The first, used for validation and the stabil- SF Alka (for reconstitution). The suspen- ity study, was a Perkin Elmer 200-Series sion was stored in a low-actinic plastic prescription bottle at a concentration of (Lot 107148; Fisher Scientific, Pittsburgh, a quaternary gradient solvent delivery sys- 2 mg/mL under United States Pharmaco- peia (USP) refrigerated (2oC to 8oC) storage tahydrate (Lot B0131737; Acros Organics, conditions. Stability was assessed by per- Geel, Belgium), and octanesulfonic acid (Lot with a Peltier tray, 200-mcL sample loop, cent recovery studies performed at varying souri) were used in the study. HPLC-grade tem, used for forced degradation studies, was a Varian Prostar (Palo Alto, California) equipped with a tertiary gradient solvent The authors are affiliated with Dynalabs, LLC, St. Louis, Missouri.

OMEPRAZOLE+SYRSPEND SF ALKA WARNING

Studies indicate that people who take proton pump inhibitor medications (such as Nexium) may be at an increased risk for broken bones. The risk appears to be highest for people who take such medications at high doses or for long periods (over a year). You and your healthcare provider should take this into account when deciding if the benefits of this medication outweigh the risks for your particular situation.

The use of proton pump inhibitors (including this medication) may increase the risk of a potentially serious condition known as Clostridium difficile-associated diarrhea (CDAD). If you develop diarrhea that does not seem to improve (especially if it is watery and accompanied by a fever and abdominal pain), seek immediate medical attention.

The prominent consumer watchdog group Public Citizen has filed a petition with the FDA, indicating that a new black box warning for Nexium, Prilosec and other proton pWe bring forth an array of Antacid Medicines that are formulated by dexterous professionals who are guided by medical experts. Available in syrup form, these antacids are consumed for counteracting stomach acidity. Moreover, these act as stomach acid neutralizers, which reduces or blocks the secretion of acid driven by gastric cells. In order to meet urgent demands of the clients, we have these antacids available in bulk quantity with us. Free from any kind of side-effect, these products are ensured for their longer shelf life and ability to improve consumers' health.

The Magaldrate and Simethicone Oral Suspension (Antacid Drugs) that we manufacture and supply are used to relieve several stomach problems. Their main purpose is to neutralize excess stomach acid. They are highly effective in providing quick relief and for a longer period of time.

Treating acid indigestion, heartburn, gas, and sour stomach. It may also be used for other conditions as determined by your doctor.

Magaldrate/simethicone suspension is an antacid and antiflatulent combination. The antacid works by neutralizing stomach acid and increasing the pH of the stomach. The antiflatulent works by breaking up gas bubbles, which makes gas easier to eliminate.

This may not be a complete list of all interactions that may occur. Ask your health care provider if magaldrate/simethicone suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.ump inhibitor drugs is necessary to warn consumers and the medical community about the risk of long-term dependence and other dangerous side effects.


According to the petition (PDF) filed with the FDA on Tuesday, Public Citizen indicates that the strongest possible warning label is necessary for the widely used acid reflux drugs, which were prescribed more than 119 million times in 2009 and generated sales in the United States of $13.6 billion.

An estimated one out of every 20 people in the developed world are currently taking a proton pump inhibitor (PPI) to reduce the production of stomach acid in an attempt to alleviate symptoms of gastroesophageal reflux disease (GERD), ulcers and other stomach ailments. In addition to Nexium and Prilosec, other drugs in the same class included Prevacid, Zegerid, Protonix, Dexilant, Aciphex, Vimovo and a number of generic equivalents.

The prominent consumer watchdog group Public Citizen has filed a petition with the FDA, indicating that a new black box warning for Nexium, Prilosec and other proton pump inhibitor drugs is necessary to warn consumers and the medical community about the risk of long-term dependence and other dangerous side effects.�

According to the petition (PDF) filed with the FDA on Tuesday, Public Citizen indicates that the strongest possible warning label is necessary for the widely used acid reflux drugs, which were prescribed more than 119 million times in 2009 and generated sales in the United States of $13.6 billion.

An estimated one out of every 20 people in the developed world are currently taking a proton pump inhibitor (PPI) to reduce the production of stomach acid in an attempt to alleviate symptoms of gastroesophageal reflux disease (GERD), ulcers and other stomach ailments. In addition to Nexium and Prilosec, other drugs in the same class included Prevacid, Zegerid, Protonix, Dexilant, Aciphex, Vimovo and a number of generic equivalents.

- See more at: http://www.aboutlawsuits.com/black-box-warnings-nexium-prilosec-ppi-20578/#sthash.tsY5GfDG.dpuf

The prominent consumer watchdog group Public Citizen has filed a petition with the FDA, indicating that a new black box warning for Nexium, Prilosec and other proton pump inhibitor drugs is necessary to warn consumers and the medical community about the risk of long-term dependence and other dangerous side effects.�

According to the petition (PDF) filed with the FDA on Tuesday, Public Citizen indicates that the strongest possible warning label is necessary for the widely used acid reflux drugs, which were prescribed more than 119 million times in 2009 and generated sales in the United States of $13.6 billion.

An estimated one out of every 20 people in the developed world are currently taking a proton pump inhibitor (PPI) to reduce the production of stomach acid in an attempt to alleviate symptoms of gastroesophageal reflux disease (GERD), ulcers and other stomach ailments. In addition to Nexium and Prilosec, other drugs in the same class included Prevacid, Zegerid, Protonix, Dexilant, Aciphex, Vimovo and a number of generic equivalents.

- See more at: http://www.aboutlawsuits.com/black-box-warnings-nexium-prilosec-ppi-20578/#sthash.tsY5GfDG.dpuf
OMEPRAZOLE+SYRSPEND SF ALKA USES

Omeprazole is used in the treatment of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger-Ellison syndrome. Omeprazole is marketed by AstraZeneca under a number of names, most notably Prilosec and Losec, as well as being available from a number of generic manufacturers. Omeprazole is available in both tablet and capsule form, with varying strengths of each. The need for other administration options for those patients who cannot take tablets or capsules has led compounding pharmacies to seek other alternatives. One possible alternative is the use of a suspending agent to create an oral solution or suspension. In the past, this has been accomplished using a sodium bicarbonate solution as the vehicle.

How to use Omeprazole+SyrSpend SF Alka

However, sodium bicarbonate/omeprazole combination imparts a bitter and unpleasant taste. SyrSpend SF Alka (reconstituted) is a vehicle for making a suspension which has a pleasant taste, thus increasing palpability and compliance. The objective of this study was to determine the stability of omeprazole in SyrSpend SF Alka (for reconstitution). The studied sample was compounded into a 2-mg/mL suspension and stored in a low-actinic plastic prescription bottle at temperatures between 2 degrees C and 8 degrees C. Six samples were assayed at each time point out to 92 days by a stability-indicating high-performance liquid chromatography method. The method was validated for its specificity through forced degradation studies. The shelf life of this product is at least 92 days, based on data collected when refrigerated and protected from light.

OMEPRAZOLE+SYRSPEND SF ALKA SIDE EFFECTS

Does Omeprazole+SyrSpend SF Alka oral interact with other medications?

Omeprazole+SyrSpend SF Alka oral may interact with the following medications

Severe Interactions of Omeprazole+SyrSpend SF Alka oral:
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

In the US -

Call your doctor for medical advice about side effects. You may report side effects to FDA.

In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada.

OMEPRAZOLE+SYRSPEND SF ALKA PRECAUTIONS

Before taking this product, tell your doctor or pharmacist if you are allergic to famotidine; or to other acid blockers (e.g., cimetidine, ranitidine); or to other antacids containing calcium/magnesium; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

If you have any of the following health problems, consult your doctor or pharmacist before using this product: kidney problems, liver problems, other stomach problems (e.g., tumors).

Some symptoms may actually be signs of a more serious condition. Get medical help right away if you have: heartburn with lightheadedness/sweating/dizziness, chest/jaw/arm/shoulder pain (especially with shortness of breath, unusual sweating), unexplained weight loss.

In addition, before you self-treat with this medication, get medical help right away if you have any of these signs of a serious condition: trouble/pain swallowing food, bloody vomit, vomit that looks like coffee grounds, bloody/black stools, heartburn for over 3 months, frequent chest pain, frequent wheezing (especially with heartburn), nausea/vomiting, stomach pain.

Do not use this medication in children younger than 12 unless directed by the doctor.

Older adults may be more sensitive to the side effects of this drug, especially confusion.

During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor. Tell your doctor if you are pregnant before using this medication.

This drug passes into breast milk. Consult your doctor before breast-feeding.

OMEPRAZOLE+SYRSPEND SF ALKA INTERACTIONS

Does Omeprazole+SyrSpend SF Alka interact with other medications?

Omeprazole+SyrSpend SF Alka may interact with the following medications:

Severe Interactions of Omeprazole+SyrSpend SF Alka:

These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

PROTON PUMP INHIBITORS/RILPIVIRINE
PROTON PUMP INHIBITORS/ATAZANAVIR; NELFINAVIR

Serious Interactions of Omeprazole+SyrSpend SF Alka:

These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

OMEPRAZOLE+SYRSPEND SF ALKA OVERDOSE

If overdose is suspected, contact a poison control center or emergency room immediately. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.

Notes

No monograph available at this time.

Missed Dose

Consult your pharmacist.

Storage

Consult your pharmacist.

Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company for more details about how to safely discard your product.

Information last revised March 2013. Copyright(c) 2013 First Databank, Inc.

Share the joy